Clinical Trial Update: Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the PA5346 Ocular Implant for safety, tolerability, biodegradation and potential efficacy signals in open-angle glaucom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PA5346 Ocular Implant

Snippet

Sponsor: PolyActiva Pty Ltd | Conditions: Open Angle Glaucoma (OAG), Ocular Hypertension (OH) | Phase 1 | Status: RECRUITING